Advertisement

Topics

Amarantus Therapeutics, Inc. Company Profile

02:23 EST 23rd November 2017 | BioPortfolio

Amarantus Therapeutics, Inc. is a privately-held biotechnology company developing first-in-class disease–modifying treatments that address the underlying cause of cell death, known as apoptosis, associated with a wide range of diseases, including but not limited to, neurodegenerative and cardiovascular. The Company’s most advanced drug candidate, AMRS001, is a growth factor indicated for the treatment of Parkinson’s disease and Myocardial Infarction. Currently incubating at the Parkinson’s Institute, Amarantus Therapeutics is seeking to raise a $1 million investment as a bridge to a $15 million Series A that it will use to advance its lead programs in Parkinson’s and Myocardial Infarction into clinical development. www.amarantustherapeutics.com


News Articles [535 Associated News Articles listed on BioPortfolio]

Amarantus Bioscience Holdings Inc AMBS Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryAmarantus Bioscience Holdings Inc Amarantus, formerly Amarantus BioSciences Inc is a biotechnology company that discovers and develops treatments for various therapeutic diseases. The company's...

Amarantus Bioscience Holdings Inc Medical Equipment Deals and Alliances Profile [Report Updated: 17102017] Prices from USD $250

SummaryAmarantus Bioscience Holdings Inc Amarantus, formerly Amarantus BioSciences Inc is a biotechnology company that discovers and develops treatments for various therapeutic diseases. The company's...

Amarantus Bioscience Holdings Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17102017] Prices from USD $250

SummaryAmarantus Bioscience Holdings Inc Amarantus, formerly Amarantus BioSciences Inc is a biotechnology company that discovers and develops treatments for various therapeutic diseases. The company's...

Amarantus Bioscience Holdings Inc AMBS Medical Equipment Deals and Alliances Profile [Report Updated: 11072017] Prices from USD $250

SummaryAmarantus Bioscience Holdings Inc Amarantus, formerly Amarantus BioSciences, Inc., discovers and develops treatments for various therapeutic diseases. The company's therapeutics pipeline produc...

Amarantus Bioscience Holdings Inc AMBS Pharmaceuticals Healthcare Deals and Alliances Profile. [Report Updated: 20072017] Prices from USD $250

SummaryAmarantus Bioscience Holdings Inc Amarantus, formerly Amarantus BioSciences, Inc., discovers and develops treatments for various therapeutic diseases. The company's therapeutics pipeline produc...

Concurrent with BMS acquisition, IFM Therapeutics spins off IFM Therapeutics LLC

Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC.

Deals this week: Nabriva Therapeutics, LifeMine Therapeutics, Aldeyra Therapeutics

Nabriva Therapeutics plans to raise $80m through an underwritten public offering of shares of its common stock.

ProQR spins out Amylon Therapeutics for CNS therapeutics

ProQR Therapeutics has spun out Amylon Therapeutics, a privately-held company focused on the development of therapies for central nervous system (CNS) disorders, with seed funding from a group of inst...

Clinical Trials [122 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1172 Associated Companies listed on BioPortfolio]

Amarantus Therapeutics, Inc.

Amarantus Therapeutics, Inc. is a privately-held biotechnology company developing first-in-class disease–modifying treatments that address the underlying cause of cell death,...

Amarantus BioSciences, Inc.

Amarantus BioSciences, Inc. is a California-based development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surround...

Amarantus BioScience Holdings, Inc.

Amarantus is a development-stage biotechnology company founded in January 2008. The Company is focused on developing unique products and proprietary technologies for the potential...

Amarantus BioScience, Inc.

Amarantus BioScience, Inc. is a development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surrounding the intellectu...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

More Information about "Amarantus Therapeutics, Inc." on BioPortfolio

We have published hundreds of Amarantus Therapeutics, Inc. news stories on BioPortfolio along with dozens of Amarantus Therapeutics, Inc. Clinical Trials and PubMed Articles about Amarantus Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Amarantus Therapeutics, Inc. Companies in our database. You can also find out about relevant Amarantus Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record